Literature DB >> 27733728

Racial Differences in the Cholesterol-Lowering Effect of Statin.

Ryo Naito1, Katsumi Miyauchi, Hiroyuki Daida.   

Abstract

Statin treatment to reduce low-density lipoprotein cholesterol (LDL-C) is associated with the prevention of cardiovascular events in Western patients. Similar results have been reported in studies conducted in Japan. However, the dose of statins and the degree of LDL-C reduction achieved with statins are different between Asian and Western patients. In addition, there are limited data regarding racial differences in response to statins. In this review, racial differences between Asians and Westerners in response to statins are described.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27733728      PMCID： PMC5225129          DOI： 10.5551/jat.RV16004

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


  40 in total

1.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Authors:  A Endo; M Kuroda; Y Tsujita
Journal:  J Antibiot (Tokyo)       Date:  1976-12       Impact factor: 2.649

2.  Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study.

Authors:  Luca Puccetti; Federica Ciani; Alberto Auteri
Journal:  Atherosclerosis       Date:  2010-02-25       Impact factor: 5.162

3.  ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

Authors:  J E Keskitalo; O Zolk; M F Fromm; K J Kurkinen; P J Neuvonen; M Niemi
Journal:  Clin Pharmacol Ther       Date:  2009-05-27       Impact factor: 6.875

4.  Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies.

Authors:  Miao Hu; Sandra S H Lui; Gary T C Ko; Brian Tomlinson
Journal:  Int J Cardiol       Date:  2013-05-01       Impact factor: 4.164

5.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

6.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

7.  ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.

Authors:  B Tomlinson; M Hu; V W Y Lee; S S H Lui; T T W Chu; E W M Poon; G T C Ko; L Baum; L S Tam; E K Li
Journal:  Clin Pharmacol Ther       Date:  2010-02-03       Impact factor: 6.875

8.  The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

Authors:  Deepak Voora; Svati H Shah; Ivan Spasojevic; Shazia Ali; Carol R Reed; Benjamin A Salisbury; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

9.  Pharmacogenetic study of statin therapy and cholesterol reduction.

Authors:  Daniel I Chasman; David Posada; Lakshman Subrahmanyan; Nancy R Cook; Vincent P Stanton; Paul M Ridker
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

10.  Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.

Authors:  Yuji Matsuzawa; Toru Kita; Hiroshi Mabuchi; Masunori Matsuzaki; Noriaki Nakaya; Shinichi Oikawa; Yasushi Saito; Jun Sasaki; Kazuaki Shimamoto; Hiroshige Itakura
Journal:  Circ J       Date:  2003-04       Impact factor: 2.993
View more
  25 in total

1.  Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults.

Authors:  Raju Kanukula; Abdul Salam; Anthony Rodgers; Bishoy Kamel
Journal:  Clin Pharmacokinet       Date:  2021-01-11       Impact factor: 6.447

Review 2.  A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms.

Authors:  Carl E Orringer; Jelani K Grant; Lale Tokgozoglu
Journal:  Curr Atheroscler Rep       Date:  2022-08-24       Impact factor: 5.967

Review 3.  Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.

Authors:  Gerald F Watts; Samuel S Gidding; Pedro Mata; Jing Pang; David R Sullivan; Shizuya Yamashita; Frederick J Raal; Raul D Santos; Kausik K Ray
Journal:  Nat Rev Cardiol       Date:  2020-01-23       Impact factor: 32.419

4.  Statin Responses in Chinese Patients.

Authors:  Brian Tomlinson; Paul Chan; Zhong-Min Liu
Journal:  J Atheroscler Thromb       Date:  2017-07-21       Impact factor: 4.928

Review 5.  Nonadherence to statins: individualized intervention strategies outside the pill box.

Authors:  Peter Lansberg; Andre Lee; Zhen-Vin Lee; Kannan Subramaniam; Sajita Setia
Journal:  Vasc Health Risk Manag       Date:  2018-05-24

Review 6.  2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.

Authors:  Mee Kyoung Kim; Seung Hyun Ko; Bo Yeon Kim; Eun Seok Kang; Junghyun Noh; Soo Kyung Kim; Seok O Park; Kyu Yeon Hur; Suk Chon; Min Kyong Moon; Nan Hee Kim; Sang Yong Kim; Sang Youl Rhee; Kang Woo Lee; Jae Hyeon Kim; Eun Jung Rhee; SungWan Chun; Sung Hoon Yu; Dae Jung Kim; Hyuk Sang Kwon; Kyong Soo Park
Journal:  Diabetes Metab J       Date:  2019-08       Impact factor: 5.376

7.  Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin.

Authors:  Jo-Jo Hai; Yuen-Kwun Wong; Chun-Ka Wong; Ka-Chun Un; Pak-Hei Chan; Chung-Wah Siu; Kai-Hang Yiu; Chu-Pak Lau; Hung-Fat Tse
Journal:  BMC Cardiovasc Disord       Date:  2019-07-15       Impact factor: 2.298

8.  Statin Intolerance-An Asian Perspective.

Authors:  Brian Tomlinson; Paul Chan; Zhong-Min Liu
Journal:  J Atheroscler Thromb       Date:  2019-09-25       Impact factor: 4.928

9.  Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention.

Authors:  Yun Wang; Bryan Ping Yen Yan; Brian Tomlinson; Michael Bruce Nichol; Vivian Wing Yan Lee
Journal:  J Atheroscler Thromb       Date:  2018-06-29       Impact factor: 4.928

10.  Total cholesterol and mortality from ischemic heart disease and overall cardiovascular disease in Korean adults.

Authors:  Daeho Kwon; Jee-Jeon Yi; Heechoul Ohrr; Sang-Wook Yi
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.